Download PDF
Thromb Haemost 2008; 100(01): 167-168
DOI: 10.1160/TH08-03-0199
Letters to the Editor
Schattauer GmbH

Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter

Melina Verso
1   Medicina Interna e Cardiovascolare-Stroke Unit, Università di Perugia, Perugia, Italy
,
Giancarlo Agnelli
1   Medicina Interna e Cardiovascolare-Stroke Unit, Università di Perugia, Perugia, Italy
› Author Affiliations
Further Information

Publication History

Received 30 March 2008

Accepted 16 May 2008

Publication Date:
22 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Bern HM, Lokich JJ, Wallach SR. et al. Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Ann Inter Med 1990; 112: 423-428.
    CrossrefPubMedGoogle Scholar
  • 2 Monreal M, Alastrue A, Rull M. et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Verso M, Agnelli G, Bertoglio S. et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheters: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
    CrossrefPubMedGoogle Scholar
  • 4 Karthaus M, Kretzschmar A, Kröning H. et al. A Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
    CrossrefPubMedGoogle Scholar
  • 5 Couban S, Goodyear M, Burnell M. et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
    CrossrefPubMedGoogle Scholar
  • 6 Young AM, Begum G, Billingham LJ. WARP-a multicentre, prospective, randomized controlled trial of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). Ann ASCO Meet. 2005 Abstr 8004..
    PubMedGoogle Scholar
  • 7 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism. Chest 2004; 126: 338S-400S.
    CrossrefPubMedGoogle Scholar
  • 8 Chaukiyal P, Nautiyal A, Radhakrishnan S. et al. Thromboprophylaxis in cancer patietns with central venous catheters. A systematic review and metanalysis. Thromb Haemost 2008; 99: 38-43.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 3665-3675.
    CrossrefPubMedGoogle Scholar
  • 10 Agnelli G, Verso M. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. J Thromb Haemost 2006; 04: 14-15.
    CrossrefPubMedGoogle Scholar
  • 11 Agnelli G, Verso M. Therapy insight: venous catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 2006; 03: 214-222.
    CrossrefPubMedGoogle Scholar
  • 12 Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. J Am Med Assoc 2005; 293: 715-722.
    CrossrefPubMedGoogle Scholar
  • 13 Lee AYY, Levine MN, Butler G. et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
    CrossrefPubMedGoogle Scholar
  • 14 Dentali F, Gianni M, Agnelli G. et al. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost 2008; 06: 70-75.
    PubMedGoogle Scholar
  • 15 Verso M, Agnelli G, Kamphuisen P. et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheterin cancer patients. Intern Emerg Med. 2008 epub ahead of print
    PubMedGoogle Scholar